Shanghai Rendu Biotechnology Co., Ltd. (SHA:688193)

SHA:688193 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	261.58	609.57	298.93	197.94	171.98
Short-Term Investments	-	125.66	-	-	-
Trading Asset Securities	510.96	50.21	530.98	-	-
Cash & Short-Term Investments	772.54	785.44	829.91	197.94	171.98
Cash Growth	-1.64%	-5.36%	319.27%	15.10%	131.32%
Accounts Receivable	49.37	77.6	105.13	55.5	39.15
Other Receivables	0.51	4.83	3.54	4.29	2.16
Receivables	49.88	82.43	108.66	59.79	41.31
Inventory	25.14	28.6	28.29	19.39	16.35
Other Current Assets	37.18	2.67	5.72	5.42	0.78
Total Current Assets	884.74	899.14	972.58	282.54	230.41
Property, Plant & Equipment	82.22	92.72	100.91	87.64	71.1
Other Intangible Assets	0.41	0.45	0.66	0.6	0.52
Long-Term Deferred Tax Assets	20.24	12.96	9.63	3.23	6.15
Long-Term Deferred Charges	6.74	8.3	3.73	3.92	0.7
Other Long-Term Assets	-	41.15	1.21	0.68	1.91
Total Assets	994.36	1,055	1,089	378.61	310.79
Accounts Payable	3.04	4.09	11.38	9.84	7.96
Accrued Expenses	11.83	58.65	65.77	36.96	43.45
Short-Term Debt	-	-	-	-	3.84
Current Portion of Long-Term Debt	1.91	-	-	-	-
Current Portion of Leases	-	2.93	2.6	1.88	-
Current Income Taxes Payable	0.74	1	1.12	2.39	0.01
Current Unearned Revenue	9.01	5.58	7.33	9.22	14.45
Other Current Liabilities	47.89	6.21	7.26	6.02	7.36
Total Current Liabilities	74.42	78.45	95.46	66.31	77.07
Long-Term Leases	2.33	4.09	7.91	2.11	-
Long-Term Unearned Revenue	5.72	9.42	22.2	22.2	18
Long-Term Deferred Tax Liabilities	-	-	1.72	-	-
Other Long-Term Liabilities	0.01	0.01	0.05	0.24	0.68
Total Liabilities	82.48	91.97	127.34	90.86	95.75
Common Stock	40	40	40	30	30
Additional Paid-In Capital	777.44	773.7	776.23	135.44	127.19
Retained Earnings	129.87	149.39	146.13	122.8	58.18
Treasury Stock	-35.66	-	-	-	-
Comprehensive Income & Other	0.23	-0.35	-0.97	-0.49	-0.34
Shareholders' Equity	911.88	962.74	961.38	287.75	215.03
Total Liabilities & Equity	994.36	1,055	1,089	378.61	310.79
Total Debt	4.24	7.02	10.51	3.99	3.84
Net Cash (Debt)	768.31	778.42	819.4	193.95	168.13
Net Cash Growth	-1.30%	-5.00%	322.47%	15.36%	126.16%
Net Cash Per Share	19.67	19.79	21.42	6.39	5.59
Filing Date Shares Outstanding	39.46	40	40	30	30
Total Common Shares Outstanding	39.46	40	40	30	30
Working Capital	810.33	820.69	877.12	216.23	153.34
Book Value Per Share	23.11	24.07	24.03	9.59	7.17
Tangible Book Value	911.47	962.29	960.72	287.15	214.51
Tangible Book Value Per Share	23.10	24.06	24.02	9.57	7.15
Buildings	-	58.85	58.47	58.47	38.19
Machinery	-	71.85	67.39	48.02	32.51
Construction In Progress	-	-	-	-	18.38

Source: S&P Global Market Intelligence. Standard template. Financial Sources.